Remote Patient Monitoring for Preeclampsia
(REACH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether monitoring blood pressure from home, rather than only during doctor visits, can better manage high blood pressure during pregnancy. The researchers aim to determine if this approach improves health outcomes for both mother and baby while remaining cost-effective. Participants will either use remote patient monitoring (tracking health data from home) or continue with the usual office visits to manage their condition. Expectant mothers who are less than 23 weeks pregnant and have chronic high blood pressure might be suitable candidates. The trial focuses on making blood pressure management more frequent and convenient. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance prenatal care for future mothers.
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop your current medications. However, since the study involves adjusting blood pressure medications, you might need to change or adjust your current treatment. It's best to discuss this with the trial staff.
What prior data suggests that remote patient monitoring is safe for managing blood pressure in pregnancy?
Research has shown that pregnant women respond positively to using remote devices for blood pressure monitoring. Studies have found that this method can help control high blood pressure during pregnancy, which is crucial for the health of both mother and baby. For example, one study discovered that women using remote monitoring devices checked their blood pressure more frequently and adhered better to their monitoring routine than those using traditional methods. This suggests that the technology is safe and effective in promoting regular monitoring. No reports of negative effects from using remote monitoring itself have emerged, making it a promising option for managing high blood pressure during pregnancy.12345
Why are researchers excited about this trial?
Researchers are excited about remote patient monitoring for preeclampsia because it offers a new way to manage blood pressure from the comfort of a patient’s home. Unlike the usual care where blood pressure is checked during office visits, this approach uses technology to continuously monitor and adjust treatment based on real-time data. This method could potentially catch blood pressure changes earlier, leading to quicker interventions and better outcomes for both mothers and babies. It's a step toward more personalized and proactive care, which could transform how we handle preeclampsia.
What evidence suggests that remote patient monitoring is effective for preeclampsia?
Research has shown that remote monitoring for pregnant women with high blood pressure can improve their health. In this trial, participants in the Remote Patient Monitoring arm will have their blood pressure managed and medication adjusted based on remote measurements. Studies have found that remote monitoring simplifies access to care and enhances blood pressure management. One study discovered that remote monitoring increased the number of blood pressure checks soon after hospital discharge. Another review found it safe and practical for women at high risk of pregnancy-related high blood pressure problems. Overall, remote monitoring provides quicker and more accurate blood pressure management compared to traditional doctor visits, which is the approach used in the Usual Care arm of this trial.12678
Who Is on the Research Team?
Emily B Rosenfeld, DO
Principal Investigator
Rutgers Robert Wood Johnson Medical School
Are You a Good Fit for This Trial?
This trial is for pregnant individuals with chronic hypertension, specifically those who may be at risk of developing preeclampsia. Participants will need to have access to remote monitoring tools and be willing to monitor their blood pressure daily.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either remote patient monitoring or in-office blood pressure management, with medication titration based on blood pressure readings
Follow-up
Participants are monitored for safety and effectiveness after treatment, including composite perinatal outcomes and cardiac strain assessments
What Are the Treatments Tested in This Trial?
Interventions
- Remote Patient Monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator